Anticipatory Nausea and Vomiting with Chemotherapy
Author:
- C R BlaggCBC R Blagg
- 18 February 1982
- journal article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 306 (7) , 431-432
Abstract
To the Editor: The editorial by Laszlo and Lucas in the October 15 issue,1 along with a recent review by Seigel and Longo,2 shows that attention is being paid to the side effects of nausea and emesis as potentially limiting factors in some forms of chemotherapy. New antiemetic agents such as tetrahydrocannabinol3 and metoclopramide4 may prove useful in controlling these side effects after chemotherapy. Comparatively little is known, however, about emetic side effects that occur before a given treatment — anticipatory nausea and vomiting. Anticipatory side effects have been noted in case reports5; to our knowledge, the prevalence of . . .Keywords
This publication has 7 references indexed in Scilit:
- Emesis as a Critical Problem in ChemotherapyNew England Journal of Medicine, 1981
- Antiemetic Efficacy of High-Dose Metoclopramide: Randomized Trials with Placebo and Prochlorperazine in Patients with Chemotherapy-Induced Nausea and VomitingNew England Journal of Medicine, 1981
- The Control of Chemotherapy-Induced EmesisAnnals of Internal Medicine, 1981
- ORAL LORAZEPAM TO IMPROVE TOLERANCE OF CYTOTOXIC THERAPYThe Lancet, 1981
- INTRAVENOUS LORAZEPAM TO PREVENT NAUSEA AND VOMITING ASSOCIATED WITH CANCER CHEMOTHERAPYThe Lancet, 1981
- Antiemetics in Patients Receiving Chemotherapy for CancerNew England Journal of Medicine, 1980
- Pretreatment Nausea in Cancer Chemotherapy: A Conditioned Response?*Psychosomatic Medicine, 1980